

Developer of low molecular weight drugs for various medical needs. The company evaluates various compounds in different phases of clinical development for treating cardiovascular, cardiopulmonary, immunological and infectious diseases, as well as metabolic and central nervous system disorders. Among its major competitors, Actelion Pharmaceuticals is ranked in 8th place for NPS while Amgen is 1st, and AbbVie is 2nd.